XBUL:SFA (Bulgaria)  
Sopharma AD-Sofia logo

Sopharma AD-Sofia

лв 4.48 (0%) Nov 25
P/E:
5.55
P/B:
0.78
Market Cap:
лв 543.51M ($ 289.25M)
Enterprise V:
лв 804.69M ($ 428.25M)
Volume:
1.35K
Avg Vol (2M):
9.34K
Also Trade In:
Volume:
1.35K
Market Cap лв:
543.51M
Market Cap $:
289.25M
PE Ratio:
5.55
Avg Vol (2-Month):
9.34K
Enterprise Value лв:
804.69M
Enterprise Value $:
428.25M
PB Ratio:
0.78
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Sopharma AD-Sofia is a producer, exporter, and distributor of pharmaceutical products. It is engaged in the production of pharmaceutical products including medicines, primarily generics, herbal-based substances, and food supplements. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company operates in Bulgaria and internationally.
Name Current Vs Industry Vs History
Cash-To-Debt 0.07
Equity-to-Asset 0.57
Debt-to-Equity 0.41
Debt-to-EBITDA 1.63
Interest Coverage 10.83
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.06
Distress
Grey
Safe
Beneish M-Score -1.97
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 51.49
9-Day RSI 50.75
14-Day RSI 50.57
6-1 Month Momentum % 1.82
12-1 Month Momentum % 4.67

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.47
Quick Ratio 0.78
Cash Ratio 0.05
Days Inventory 75.45
Days Sales Outstanding 49.31
Days Payable 45.25

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Dividend Growth Rate -100
3-Year Average Share Buyback Ratio 1.1

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil лв) 1,647.185
EPS (TTM) (лв) 0.807
Beta 0
Volatility % 8.51
14-Day RSI 50.57
14-Day ATR (лв) 0.027213
20-Day SMA (лв) 4.48
12-1 Month Momentum % 4.67
52-Week Range (лв) 4 - 4.8
Shares Outstanding (Mil) 121.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sopharma AD-Sofia Filings

Document Form Filing Date
No Filing Data

Sopharma AD-Sofia Analysis

Share your research